Oncosem to Go Public!

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş., the sector leader in Turkey for chemotherapy drug preparation systems manufacturing, is going public. With 26 years of experience in the sector, the company specializes in the production of equipment, semi-finished components and medical devices used in cancer diagnosis and treatment, as well as the manufacture of diagnostic products and protective equipment.  

Exports to more than 30 countries

Currently, one out of every two chemotherapy patients in Turkey has their chemotherapy drugs prepared in systems manufactured by Oncosem. Most recently, at the beginning of the COVID-19 pandemic, the company produced antibody and antigen rapid test kits entirely with domestic resources and successfully exported these products to more than 20 countries. The company's products, including oncology products, manufactured with high technology, are exported to more than 30 countries today.

IPO proceeds to finance investments

The application to the Capital Markets Board for Oncosem's IPO was approved in the bulletin dated 15 December 2022. In the IPO managed by Info Yatırım, the company's paid-in capital is being increased from TRY 19,900,000 to TRY 23,850,000. 13 percent of the proceeds targeted from the IPO will be used to finance investments in high-technology equipment, technology transfer, clean rooms and waste systems in Germany, the United Kingdom and other overseas markets. 36 percent of the IPO proceeds will be allocated to investments in a new production facility. 28 percent of the said proceeds is planned for machinery and equipment investments aimed at increasing production capacity, while the remaining 23 percent of the offering proceeds will be allocated to financing working capital needs. Through systems established in oncology centers of 50 private and public healthcare institutions across 30 countries and Turkey, Oncosem provides support to one out of every two chemotherapy patients through benefits to both healthcare workers and patients. With the IPO, Oncosem will take this success story it has written in Turkey to the global arena.  

Share price set at TRY 17.50 per share

In the IPO to be conducted using the 'equal distribution' method, 2 million nominal shares belonging to Oncosem Board Chairman Erol Çelik will also be offered for sale. The demand collection period for the IPO is 28-29 December 2022, and the share price has been set at TRY 17.50.